United States ex rel. Phalp v. Lincare Holdings, Inc.

Decision Date26 May 2017
Docket NumberNo. 16-10532,16-10532
Citation857 F.3d 1148
Parties UNITED STATES of America, EX REL. Gerry PHALP and Matt Peoples, Plaintiffs–Appellants, v. LINCARE HOLDINGS, INC. and Lincare, Inc., d/b/a Diabetics Experts of America, Defendants–Appellees.
CourtU.S. Court of Appeals — Eleventh Circuit

Daniel W. Allen, Jose M. Bautista, Bautista & Allen, Kansas City, MO, Stephanie Anne Casey, Lindsey Lazopoulos Friedman, Curtis Bradley Miner, Colson Hicks Eidson, Coral Gables, FL, Daniel E. Gustafson, Gustafson Gluek, PLLC, Minneapolis, MN, Patrick Howard, Charles Joseph Kocher, Simon Bahne Paris, Saltz Mongeluzzi Barrett & Bendesky, PC, Philidelphia, PA, for PlaintiffsAppellants.

A. Brian Albritton, Michael S. Hooker, Lawrence P. Ingram, Phelps Dunbar, LLP, Jessica Kirkwood Alley, Freeborn & Peters LLP, Steven L. Brannock, Brannock & Humphries, PA, Tampa, FL, for DefendantsAppellees.

Weili Justin Shaw, U.S. Department of Justice, Civil Division, Appellate Staff, Washington, DC, for Amicus Curiae United States of America.

Before MARCUS and BLACK, Circuit Judges, and COHEN,* District Judge.

COHEN, District Judge:

Plaintiffs Gerry Phalp and Matt Peoples (collectively "Relators") brought a qui tam action pursuant to the False Claims Act, 31 U.S.C. §§ 3729 –3733 ("FCA"), alleging that Defendants submitted claims to Medicare without adequate authorization from the relevant Medicare beneficiaries and claims that were the product of unsolicited telemarketing calls to Medicare beneficiaries. Relators appeal summary judgments granted to Defendants with respect to each issue.

We affirm the district court with one modification. Although the district court applied an erroneous scienter standard, the evidence proffered by Relators as to Defendants' state of mind with respect to the assignment of benefits forms was insufficient to survive summary judgment under the proper standard. The district court did not err in granting summary judgment on Relators' claims that Defendants violated Medicare's unsolicited telephone contact rules.

I. BACKGROUND
A. Facts

Relators are former salespersons for Lincare, Inc. ("Lincare"), which does business as Diabetic Experts of America ("Diabetic Experts"). Defendants are Relators' former employer and related entities. Lincare supplies Medicare patients suffering from chronic obstructive pulmonary disease with oxygen, respiratory, and other therapy services. Diabetic Experts is a fictional name Lincare registered in 2004 to sell diabetic-testing supplies.1 Lincare Holdings, Inc. ("Holdings") is a holding company for its wholly-owned subsidiary, Lincare, Inc., and other subsidiaries. Additionally, Holdings supports the information systems of Lincare and Diabetic Experts by providing, among other things, a database which contains the telephone numbers for Diabetic Experts' customers.

During the relevant time period, Diabetic Experts was in the practice of supplying Medicare patients with diabetic-testing supplies. Specifically, Diabetic Experts would place calls to individuals to whom Lincare previously had provided Medicare-covered items related to chronic obstructive pulmonary disease. Diabetic Experts would offer these individuals a free diabetic-testing monitor and sell them diabetic-testing supplies, including blood-testing strips.2 After selling diabetic-testing strips to these individuals, Diabetic Experts would submit claims to Medicare using authorizations, or assignments of benefits ("AOBs"), previously provided by the Medicare beneficiaries to Lincare in connection with Lincare's provision of items related to chronic obstructive pulmonary disease. Diabetic Experts did not obtain AOBs that were specifically related to diabetic testing supplies. Instead, Diabetic Experts submitted the AOBs given to Lincare that were generic in nature and provided that the Medicare beneficiaries agreed: (1) to rent or purchase "certain medical equipment, products, supplies, prescription drugs and/or associated services" from "Lincare and its affiliates;" (2) that Lincare would provide "HME [home medical equipment] and Supplies" or "DME [durable medical equipment];" and (3) to assign Medicare benefits to Lincare.

B. Procedural Background

Relators alleged in their Second Amended Complaint ("Complaint") that Defendants violated the FCA by submitting reimbursement claims to Medicare that were non-compliant with Medicare regulations in two respects: (1) the reimbursement claims submitted by Defendants were based upon improper generic authorizations given to Lincare in connection with the provision of items related to chronic obstructive pulmonary disease and failed to include a new authorization when Defendants requested reimbursement for diabetic blood-testing strips; and (2) the claims submitted to Medicare arose out of telemarketing calls with beneficiaries that violated Medicare's unsolicited telephone contact rules. The Complaint included six examples of claims submitted by Defendants to Medicare on behalf of six different Medicare beneficiaries which were alleged to be illustrative of Defendants' unlawful conduct.

Defendants moved for summary judgment. They contended that the claims filed on behalf of these exemplars complied with the applicable Medicare regulations and could not form the basis of any FCA claim. The district court issued an order on July 13, 2015 (the "July Summary Judgment Order"), granting Defendants' motion for summary judgment on the six exemplars, but recognized the possibility that its order may not be dispositive of the entire case. United States ex rel. Phalp v. Lincare Holdings, Inc. , 116 F.Supp.3d 1326, 1361 (S.D. Fla. 2015). Subsequently, Relators cited evidence of three additional exemplars which were alleged to be illustrative of Defendants' practice of unlawfully telemarketing Medicare beneficiaries. The district court issued a second order on January 11, 2016 (the "January Summary Judgment Order"), granting Defendants' motion for summary judgment on the three additional exemplars. United States ex rel. Phalp v. Lincare Holdings, Inc. , No. 10-CV-21094, 2016 WL 3961840 (S.D. Fla. Jan. 11, 2016). Relators appeal portions of those two orders to this Court.

1. The July Summary Judgment Order

The district court held that the evidence was insufficient to create a genuine issue of material fact with regard to scienter—that is, whether the defendants "knew or should have known that its policies or practices violated the applicable statutes and implementing regulations." The district court analyzed Relators' "best evidence" of scienter, which consisted of two emails. One dealt with an entirely different compliance issue. In the second email, Lincare personnel wrote that "they [m]ay need to reconsider [their] process for Patient Agreements,’ " but the email postdated the relevant transactions by several months. The court concluded that these two emails did not "allow a reasonable jury to conclude that Diabetic Experts knowingly submitted false claims."

Citing United States ex rel. Hixson v. Health Mgt. Sys., Inc. , 613 F.3d 1186, 1191 (8th Cir. 2010), the district court stated that when a defendant claims that the governing law is ambiguous, "[t]o prevail under the False Claims Act, ‘relators must show that there is no reasonable interpretation of the law that would make the allegedly false statement true.’ " The district court expanded on this line of reasoning, stating that "a defendant's ‘reasonable interpretation of any ambiguity inherent in the regulations belies the scienter necessary to establish a claim of fraud under the FCA.’ " Based on this reasoning, as "an alternative and independent ground" for granting summary judgment in favor of Defendants,3 the court concluded "as a matter of law that, with regard to the six exemplars, no reasonable jury could find for Relators on the questions of whether Defendants submitted false claims or made or used false records with the requisite scienter."

2. The January Summary Judgment Order

At the conclusion of the July 13 Summary Judgment Order, the district court invited the parties to submit a status report indicating what, if any, claims remained in the case. Relators supplemented the record with evidence of three additional exemplars, who were previous clients of Lincare's wholly owned subsidiaries, Med4Home and Reliant. Relators alleged that Diabetic Experts' telemarketing of these beneficiaries was in violation of Medicare's prescription against unsolicited telephone contact. See 42 U.S.C. § 1395m(a)(17)(A). Relators argued that, unlike Diabetic Experts' relationship with Lincare, Med4Home and Reliant could not be considered the same supplier as Diabetic Experts for purposes of Medicare regulations.

On January 11, 2016, the district court entered its order granting summary judgment in favor of Defendants. The court found that the three additional exemplars presented by Relators fell within the exception to the anti-telemarketing prescription that applies where the beneficiary gives written permission to the Medicare supplier. See 42 C.F.R. § 424.57(c)(11)(i) ("The supplier must ... agree not to contact a beneficiary by telephone when supplying a Medicare-covered item unless ... [t]he individual has given written permission to the supplier to contact them by telephone concerning the furnishing of a Medicare-covered item that is to be rented or purchased.").4 The court subsequently granted summary judgment for Defendants on Relators' remaining claims.

II. STANDARD OF REVIEW

"We review a district court's grant of summary judgment de novo , viewing all of the facts in the record in the light most favorable to the non-movant." Haynes v. McCalla Raymer, LLC , 793 F.3d 1246, 1249 (11th Cir. 2015) (quotation and citation omitted). Summary judgment is appropriate "if the movant shows that there is no genuine dispute as to any material fact" such that "the movant is entitled to judgment as a matter of law." FED. R. CIV . P. 56(a).

"We review a district court's decision to rule on...

To continue reading

Request your trial
57 cases
  • United States ex rel. Sheldon v. Allergan Sales, LLC
    • United States
    • U.S. Court of Appeals — Fourth Circuit
    • 25 Enero 2022
    ...the Government ... to make a limited inquiry to ensure the claims they submit are accurate," United States ex rel. Phalp v. Lincare Holdings, Inc. , 857 F.3d 1148, 1155–56 (11th Cir. 2017) (quoting S. Rep. No. 99-345, at 7, 1986 U.S.C.C.A.N. at 5272).A careful review of the full record here......
  • Hillcrest Prop., LLP v. Pasco Cnty.
    • United States
    • U.S. Court of Appeals — Eleventh Circuit
    • 13 Febrero 2019
    ...judgement, "viewing all of the facts in the record in the light most favorable to the non-movant." United States ex rel. Phalp v. Lincare Holdings, Inc. , 857 F.3d 1148, 1153 (11th Cir. 2017) (quoting Haynes v. McCalla Raymer, LLC , 793 F.3d 1246, 1249 (11th Cir. 2015) ). We affirm upon a s......
  • Yates v. Pinellas Hematology & Oncology, P.A.
    • United States
    • U.S. Court of Appeals — Eleventh Circuit
    • 29 Diciembre 2021
    ...of a false claim or statement, the materiality of that false claim or statement, and scienter. See United States ex rel. Phalp v. Lincare Holdings, Inc. , 857 F.3d 1148, 1154 (11th Cir. 2017). Pinellas also asks us to overturn the jury's verdict on damages because, it says, the United State......
  • United States ex rel. Schutte v. SuperValu Inc.
    • United States
    • U.S. Court of Appeals — Seventh Circuit
    • 12 Agosto 2021
    ...(D.C. Cir. 2015). The dissent claims that the Eleventh Circuit declined to apply Safeco to the FCA in United States ex rel. Phalp v. Lincare Holdings, Inc. , 857 F.3d 1148 (11th Cir. 2017). But Phalp did not reject Safeco —it did not even cite Safeco . To support its conclusion, the dissent......
  • Request a trial to view additional results
5 firm's commentaries
3 books & journal articles
  • HEALTH CARE FRAUD
    • United States
    • American Criminal Law Review No. 58-3, July 2021
    • 1 Julio 2021
    ...in the pertinent regulations will often convince federal agents not to bring a case.”); see also United States v. Lincare Holdings, Inc., 857 F.3d 1148, 1155 (11th Cir. 2017) (f‌inding that statutory ambiguity may be relevant to the analysis, but it does not foreclose f‌inding a scienter). ......
  • Health Care Fraud
    • United States
    • American Criminal Law Review No. 59-3, July 2022
    • 1 Julio 2022
    ...fall within § 1001. 448 In the context of health care fraud, not to bring a case.”); see also United States v. Lincare Holdings, Inc., 857 F.3d 1148, 1155 (11th Cir. 2017) (f‌inding that statutory ambiguity may be relevant to the analysis, but it does not foreclose f‌inding a scienter). 441......
  • The Department of Justice's Civil Cyber-Fraud Initiative and Its Impact on the False Claims Act.
    • United States
    • Defense Counsel Journal Vol. 90 No. 1, January 2023
    • 1 Enero 2023
    ...provision of health care services" was too general to impose liability); but see United States ex rel. Phalp v. Lincare Holdings, Inc., 857 F.3d 1148 (11th Cir. 2017) (holding that "[s]cienter is not determined by the ambiguity of a regulation, and can exist even if a defendant's interpreta......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT